Other
Increase (decrease) in contract liabilities and current deferred income
West Pharmaceutical Services Increase (decrease) in contract liabilities and current deferred income increased by 631.3% to $8.50M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase signals strong future demand and booking momentum, while a decrease may indicate lower forward bookings.
Detailed definition
Represents the net change in customer deposits or advance payments received for services that have not yet been performe...
Peer comparison
Highly comparable across travel, hospitality, and subscription-based businesses.
Metric ID:
other_increase_decrease_in_contract_with_customer_liabilityHistorical Data
3 periods
| Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|
| Value | -$5.40M | -$1.60M | $8.50M |
| QoQ Change | — | +70.4% | +631.3% |
| YoY Change | — | — | +257.4% |
Range-$5.40M – $8.50M
Avg YoY Growth+257.4%
Median YoY Growth+257.4%
Current Streak2+ quarters growth
Increase (decrease) in contract liabilities and current deferred income at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's increase (decrease) in contract liabilities and current deferred income?
- West Pharmaceutical Services (WST) reported increase (decrease) in contract liabilities and current deferred income of $8.50M in Q1 2026.
- What does increase (decrease) in contract liabilities and current deferred income mean?
- The net change in advance payments received from customers for future services.